Clinical Trial Update: Modulate-CF: Cystic Fibrosis Transmembrane Regulator (CFTR) Biomarker Study to Evaluate the Rescue of Mutant CFTR in Patients With Cystic Fibrosis Treated With CFTR-modulators

View source ↗

Summary

A clinical trial update for Modulate-CF, a cystic fibrosis biomarker study assessing rescue of mutant CFTR in patients treated with CFTR modulators; recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Cystic Fibrosis | Status: RECRUITING